CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2005; 55:334-351
doi: 10.3322/canjclin.55.6.334
© 2005 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and...
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Souza, R. F.
Right arrow Articles by Spechler, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Souza, R. F.
Right arrow Articles by Spechler, S. J.

Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach

Rhonda F. Souza, MD and Stuart J. Spechler, MD


Rhonda F. Souza is Associate Professor of Medicine, Division of Gastroenterology, Dallas VA Medical Center and University of Texas Southwestern Medical School and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas.
Stuart J. Spechler is Professor of Medicine and Holder of the Berta M. and Cecil O. Patterson Chair in Gastroenterology, Dallas VA Medical Center and University of Texas Southwestern Medical Center at Dallas.

For decades, the incidence rates for squamous cell carcinoma of the esophagus and adenocarcinoma of the distal stomach have been declining while the rates for adenocarcinomas of the esophagus and gastric cardia have increased profoundly. Recent studies have shown that the gastroesophageal junction (GEJ) is regularly exposed to concentrated gastric acid and to a variety of nitrosating species, noxious agents that may contribute to carcinogenesis in this region. For adenocarcinomas that straddle the GEJ, it can be difficult to determine whether the tumor originated in the esophagus or in the gastric cardia. This classification problem hampers studies on the epidemiology and pathogenesis of GEJ tumors. Current concepts in the prevention of cancers of the distal esophagus and proximal stomach have emerged from advances in our understanding of the specific molecular events that occur during the evolution of these tumors. This report reviews those events and focuses on current concepts in the prevention of adenocarcinomas at the GEJ. The similarities and differences in risk factors, molecular pathogenesis, and in preventive strategies for adenocarcinomas of the esophagus and gastric cardia are highlighted.




This article has been cited by other articles:


Home page
Clin Med ResHome page
H. S. Vats, T. K. Banerjee, J. Resnick, and Q. Khan
Esophageal Adenocarcinoma Arising from Barrett's Dysplasia: A Case Report of Double Occurrence and Prolonged Survival after Chemotherapy.
Clin. Med. Res., September 1, 2006; 4(3): 184 - 188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by American Cancer Society.